• Insilico completes capital increase
  • Insilico expands and moves to new premises at Stuttgart site
  • Insilico expands activities for biopharmaceutical process development


  • Insilico join forces to deliver combined solutions in preclinical drug development
  • Insilico implements agile development process


  • Insilico researchers develop computer-aided models to replace animal testing
  • Insilico presents new software modules for the automated analysis of bioprocesses


  • Insilico starts using Europe’s fastest civil computer
  • BASF, DECHEMA and Insilico collaborate in a joint EU project focussing on methanol as a carbon source in industrial bioproduction
  • Insilico becomes partner in the transnational EU project entitled BioPreDyn


  • Metabolomic Discoveries and Insilico pool their expertise in applied systems biology
  • Insilico and partners start OXISYS project to combat cell ageing
  • Insilico and Evonik head for bacterial "lean production" in a joint project funded by BMBF
  • Insilico becomes partner in several EU research projects to develop non-animal testing methods for cosmetic substances
  • Insilico participates in SysEnCor joint project to investigate the energy balance of Corynebacterium glutamicum
  • Insilico moves to new premises in STEP Engineering Park


  • Insilico contributes pathway models for the EU HepatoSys Virtual Liver project
  • GenBioCom joint project profits from Insilico‘s expertise on bacterial metabolism and genome-based metabolic simulations
  • BASF and Insilico cooperate in a joint project funded by BMBF to promote the commercial use of Pseudomonas strains
  • Insilico intensifies cooperation with HLRS on High Performance Computing

2006 – 2009

  • Candida albicans joint research project starts with Insilico as contributing partner
  • Insilico becomes a member of Industrial Association Microbial Genome Research
  • Evonik launches multi-annual cooperation with Insilico
  • Insilico expands collaboration with Kluyver Centre for Genomics of Industrial Fermentation
  • Insilico plays an active role in BioIndustry 2021, a white biotechnology initiative
  • Insilico and Wacker Chemie AG enter into multi-annual cooperation
  • Insilico receives funding for systems biology research within the HepatoSys competence network
  • Insilico launches simulations on Europe’s fastest vector computer
  • Insilico changes its corporate form into AG
  • Genedata and Insilico start collaborating in the field of systems biology
  • First East Asian customer signs collaboration agreement with Insilico

2001 - 2005

  • Insilico expands and moves to the Stuttgart Technology Center
  • Evonik Degussa and Insilico widen their cooperation on systems biology
  • Degussa Food Ingredients GmbH and Insilico enter into cooperation
  • Insilico receives funding from the German Federal Ministry of Education and Research (BMBF) within the »Systems of Life - Systems Biology« initiative
  • Bayer Technology Services licenses Insilico Discovery to optimise biotechnological production processes
  • Insilico supports Systems Biology Markup Language (SBML)
  • Insilico receives Frost & Sullivan Award for Excellence in Technology
  • Insilico is nominated by the European Commission for the European Information Society Technologies Prize
  • Boehringer Ingelheim and Insilico sign collaboration agreement
  • Insilico receives start-up award from Otto Beisheim Foundation
  • September 18th, 2001: Foundation of Insilico Biotechnology GmbH in Stuttgart, Germany